Zenotech Laboratories Limited

₹38.27As of Sun 8 Nov 2026, 12:00 UTC
BSE:532039Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (1.35%)
Div yield —
ROE (4.52%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.53
PE TTM —
TSR TTM (28.45%)
Mkt cap ₹2.336B
ROIC (5.19%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹46
19.47%
(3.80%)
Hold 8|6|11|6|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.45
0.43
0.48
0.47
17.62%
8.39%
11.16%
(0.44%)
Revenue₹M
148.5
149.7
146.8
149.0
3.51%
3.05%
(2.29%)
(1.90%)
Peers (US$24.98M)
Cap (US$)
PE
191.2M
61.34x
26.04M
—
Capital
TTM
5Y
10Y
Leveragex
0.757
(0.019)
(0.018)
EBIT/Intx
1.240
0.506
0.436
Own earn%
112.27
57.85
46.67
Sh yield%
36.34
40.90
42.83
Owners
Insiders/Inst%
5.58
87.97
Short interest%
3.19
SBC / revenue%
0.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
8